Capillary Biomedical

๐Ÿ“ Irvine, United States๐Ÿ—“ Founded 2014๐Ÿ‘ฅ 10 employees๐Ÿ’ฐ Last funded 2020
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system. CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy. The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
5
Total investors
1
Early stage
3
Mid stage
1
Late stage
2014
Founded
Investor geography1 country
United States
5
Investor activity1962โ€“2020 ยท investors recorded per year
196212018320201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Capillary Biomedical?
Capillary Biomedical has 5 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage and 1 late-stage investors.
When did Capillary Biomedical last raise funding?
The most recent investment in Capillary Biomedical recorded on gritt.io was in 2020.
When was Capillary Biomedical founded?
Capillary Biomedical was founded in 2014.
What industry is Capillary Biomedical in?
Capillary Biomedical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Capillary Biomedical based?
Capillary Biomedical is headquartered in Irvine, United States.